Blair William & Co. IL Cuts Stake in Kenvue Inc. (NYSE:KVUE)

Blair William & Co. IL cut its holdings in Kenvue Inc. (NYSE:KVUE) by 57.0% during the second quarter, Holdings Channel reports. The firm owned 563,746 shares of the company’s stock after selling 747,380 shares during the quarter. Blair William & Co. IL’s holdings in Kenvue were worth $10,249,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in KVUE. Manchester Capital Management LLC boosted its position in shares of Kenvue by 80.8% during the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock worth $25,000 after acquiring an additional 530 shares during the last quarter. Mather Group LLC. purchased a new stake in Kenvue in the 1st quarter worth $28,000. Riverview Trust Co bought a new position in shares of Kenvue during the 1st quarter valued at about $33,000. MV Capital Management Inc. grew its position in shares of Kenvue by 71.2% during the first quarter. MV Capital Management Inc. now owns 1,544 shares of the company’s stock valued at $33,000 after purchasing an additional 642 shares in the last quarter. Finally, Salomon & Ludwin LLC bought a new stake in shares of Kenvue in the first quarter worth about $33,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Royal Bank of Canada reissued an “outperform” rating and set a $24.00 price target on shares of Kenvue in a research note on Wednesday, August 7th. UBS Group increased their target price on Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. JPMorgan Chase & Co. boosted their price target on shares of Kenvue from $22.00 to $24.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, Citigroup dropped their price objective on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research note on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $21.44.

Kenvue Price Performance

Kenvue stock opened at $22.90 on Friday. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $23.55. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average price of $20.83 and a 200-day moving average price of $19.93. The firm has a market capitalization of $43.85 billion, a PE ratio of 29.36, a price-to-earnings-growth ratio of 2.92 and a beta of 1.40.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.04. The business had revenue of $4 billion during the quarter, compared to analyst estimates of $3.93 billion. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company’s revenue for the quarter was down .3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 earnings per share. As a group, equities research analysts forecast that Kenvue Inc. will post 1.08 EPS for the current year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Shareholders of record on Wednesday, August 14th were given a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.58%. The ex-dividend date was Wednesday, August 14th. This is an increase from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s dividend payout ratio is 105.13%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.